Why Thalassemia Screening Can’t Wait: A Vital Step for Health

Every year, on May 8, we observe World Thalassemia Day. Its objective is to remind us, medical professionals and other stakeholders, of the resilience of patients living with this genetic blood disorder and the urgency of improving care. But this year’s theme, “Together for Thalassaemia: Uniting Communities, Prioritising Patients,” resonates deeply with me, because  as a doctor, I have seen the silent struggles thalassemia patients and their families face every day.

For the last 18 years that I have been practising as a hematologist, I meet children who’ve never known a life without blood transfusions. Some have to undergo transfusions every 2–4 weeks, bravely enduring needle pricks and long hospital hours. Their parents, though emotionally exhausted, try to stay strong. And while their bodies often show remarkable resilience, their stories lay bare the deep fissures in our healthcare systems, care delivery, and collective awareness.

India sees about 10,000–12,000 new thalassemia births every year. With over 1, 00,000 patients currently living with the disease, the burden is massive. Yet, thalassemia remains a lesser-known disorder outside medical circles. Most couples, who are carriers, remain unaware of their carrier status until their child is diagnosed. It is because preventive screening is still not routine in the country.

Treatment for thalassemia primarily involves regular blood transfusions, followed by iron chelation therapy to manage iron overload — a side effect of lifelong transfusions. But this is not enough. We must start viewing these patients as individuals with emotional, social, and financial needs that extend beyond the hospital bed.

Access to safe and timely transfusions, compatible blood, and proper iron chelation is a challenge in many parts of the country. Added to this are the psychosocial stresses — the stigma, school dropouts, missed career opportunities, and mental health issues — especially among adolescents and young adults.

Curative options like bone marrow transplants and emerging gene therapies offer hope. I’ve myself done many haploidentical transplants and have seen children resuming their normal life. But affordability of BMT procedure remains a major hurdle. These families often rely on NGOs, CSR funds, or crowdfunding to access such treatments.

This is why this year’s theme is so crucial. It calls on all of us — healthcare providers, policymakers, NGOs, researchers, and communities — to come together, put patients at the heart of care, and advocate for systemic change. 

We need stronger public awareness and carrier screening programs, financial support systems for treatment and transplants, inclusion of mental health in thalassemia care plans, and policies that integrate thalassemia care into primary healthcare.

As caregivers, citizens, and policymakers, we each have a role to play. It’s time to move beyond awareness and take sustained action to ensure every child with thalassemia has access to timely care, support, and hope.